At the ongoing J.P. Morgan Healthcare Conference, Inspire Medical Systems boasted a five-year revenue set to grow at a CAGR of more than 50%, with $912m in 2025 and a projected $1.003bn–1.013bn in ...
Inspire Medical Systems, Inc. (NYSE:INSP), a leader in neurostimulation technology for obstructive sleep apnea (OSA), recently presented its Q4 2025 financial results and corporate overview. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results